BioHealth News
Maryland Daily Record: Germantown’s new incubator expected to spur regional biosciences growth
In Montgomery County, where incubator spaces are in high demand and existing facilities often have to turn away new entrepreneurs and startups, a new…
Read MoreWelldoc Announces Collaboration to Support Cardiometabolic Health by Integrating AI-Driven Digital Coaching with Instacart’s Innovative Technology Platform to Increase Access to Nutritious Groceries
COLUMBIA, Md., June 25, 2024 — Welldoc®, a leading digital health company specializing in AI-driven cardiometabolic health, today announced a collaboration with Instacart, the leading…
Read MoreTransforming Healthcare: The FDA’s Dr. Michelle Tarver on New Initiatives and the Future of Medical Devices on the BioTalk Podcast
Join us for a compelling episode of BioTalk with Rich Bendis as we welcome Dr. Michelle E. Tarver, Deputy Center Director and Chief…
Read MoreREGENXBIO Announces Expansion of AFFINITY DUCHENNE® Trial to Include a New Cohort of Younger Patients
ROCKVILLE, Md., June 24, 2024 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it initiated enrollment in a new cohort of patients ages 1-3 in its Phase I/II…
Read MoreAscentage Pharma Announces Closing of US$75 Million Equity Investment by Takeda
ROCKVILLE, Md. and SUZHOU, China, June 20, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB),…
Read MoreEmergent BioSolutions Announces Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals for $30 Million
GAITHERSBURG, Md., June 20, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has entered into a definitive agreement to sell its drug product…
Read MoreNSF boosts funding amounts for SBIR/STTR Phase I and Phase II programs to better support the nation’s innovation and entrepreneurship community
Small businesses can receive about $2 million to create a prototype and commercialize technology. The U.S. National Science Foundation has released new funding opportunities for its Small…
Read MoreRichmondBizSense: Life sciences startup support program looks to boost biohealth industry in Richmond
Ianne Salvosa June 18, 2024 - Efforts are afoot to make Richmond more of a player in the biohealth industry. Downtown-based Activation Capital is…
Read MoreUMD Receives Entrepreneurial University Award at Annual Innovation Symposium
College Park, Md.—The University of Maryland was spotlighted for its innovative curriculum and robust student engagement in entrepreneurship at the annual Deshpande Symposium on Innovation…
Read MoreBizJournals: A thriving quality of life in Montgomery County with TEDCO
By Tammi Thomas – Chief Development and Marketing Officer, TEDCO - Jun 17, 2024 Montgomery County, Maryland, is home to a thriving ecosystem of innovators and researchers…
Read MoreUnlock Your Innovation Potential with BioHealth Innovation’s Grant Mapping Services
Navigating the complex landscape of non-dilutive funding can be daunting for many innovators and researchers. Identifying suitable grants that align with specific project goals…
Read MoreNorthwest Biotherapeutics Announces Exclusive In-License of Portfolio of Dendritic Cell Technology and Intellectual Property
BETHESDA, Md., June 17, 2024 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that…
Read MoreAscentage Pharma Signs Option Agreement with Takeda to Enter into Exclusive Global License for Olverembatinib, a Third-Generation BCR-ABL Tyrosine Kinase Inhibitor (TKI)
ROCKVILLE, Md. and SUZHOU, China, June 14, 2024 /PRNewswire/ -- Ascentage Pharma (6855 HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B…
Read MoreLeading the Charge in Tech-Based Economic Development: A Conversation with Dan Berglund of SSTI on BioTalk
Join us for an enlightening episode of BioTalk with Rich Bendis as we welcome Dan Berglund, President and CEO of SSTI. With nearly four…
Read MoreSeraxis Wins Maryland Stem Cell Research Fund Grant to Accelerate Development of Allogenetically Compatible Pancreatic Islet Replacement Therapy for Functional Cure of T1D
GERMANTOWN, MD / ACCESSWIRE / June 14, 2024 / Seraxis, Inc., a regenerative medicine company developing pancreatic islet replacement therapies to transform the lives of…
Read More